Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Autolus Therapeutics plc AUTL

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 16, 2026 8-K 3 signals fired
Other
Auditor Appointment Ratification Auditor Change Employment Termination Upon Death
Apr 8, 2026 8-K 7 signals fired
Core
Clinical Trial Result Combination Therapy Mentioned
Other
Safety Differentiated Interim Data Positive Publication Positive Patient Retention High Car T Cell Therapy
Mar 27, 2026 8-K 19 signals fired · top 15
Other
Net Loss Reported Interim Data Positive Patient Retention High Liquidity Position Snapshot Disclosed Car T Cell Therapy Enrollment Ahead Of Schedule Publication Positive Fast Track Granted Fast Track Designation Received Rmat Designation Received Fda Aligned Expanded Access Program Active
Core
Clinical Trial Result Lead Asset Progress
Healthcare
Utilization Improving
Jan 26, 2026 8-K 1 signal fired
Other
Non Assignment Clause
Jan 12, 2026 8-K 18 signals fired · top 15
Core
Clinical Trial Result Lead Asset Progress
Other
Car T Cell Therapy Interim Data Positive Patient Retention High Enrollment Ahead Of Schedule Auditor Appointment Ratification Publication Positive Fast Track Granted Fast Track Designation Received Fda Aligned Rmat Designation Received Safety Differentiated Expanded Access Program Active
Biotech Risk
Clinical Hold Active
Dec 2, 2025 8-K 4 signals fired
Other
Executive Educational Background Disclosure Rsu Psu Vesting Schedule Disclosed Car T Cell Therapy Classified Board Director Election
Nov 12, 2025 8-K 34 signals fired · top 15
Core
Secondary Endpoint Mentioned Clinical Trial Result Management Exodus Indication Expansion
Other
Net Loss Reported Car T Cell Therapy Patient Retention High Rmat Designation Received Interim Data Positive Executive Transition Gratitude Statement Fast Track Granted Mrna Drug Platform Enrollment Ahead Of Schedule
Biotech Risk
Clinical Hold Active
Biotech v3
Ind Submission Planned
Nov 12, 2025 10-Q 37 signals fired · top 15
Other
Rsu Psu Vesting Schedule Disclosed Financing Activities Cash Flow Disclosure Net Loss Reported Cash Flow Statement Investing Activities Valuation Allowance Deferred Tax Disclosure Patient Retention High Interim Data Positive Interest Income Year Over Year Comparison Quarterly Tax Provision Benefit Disclosure Rmat Designation Received Equity Plan Share Reserve Disclosure Inventory Writedown Reimbursement Price Pressure Risk Mrna Drug Platform
Core
Clinical Trial Result